Li RR, Li B, Yang XL, Zhou HJ, et al. Fruquintinib with programmed cell death - 1 inhibitors versus triflueridine - tipiracil - 102 with bevacizumab in late-line mCRC: A retrospective cohort study based on propensity score matching. Int J Cancer 2026;158:2253-2259.
PMID: 41684147